Skip to main content

Animations

MJFF Publications

5851 - 5860 of 9033 Results
Title
Year
  • Year
  • 2022
  • 2019
  • 2025
  • 2018
  • 2026
  • 2023
  • 2017
  • 2018
  • 2019
  • 2013
  • Summary Details
    OPEN
    Title: Cellular localization of p-tau217 in brain and its association with p-tau217 plasma levels
    Journal Name: Acta Neuropathologica Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s40478-021-01307-2
    Citation Count: 62
  • Expert comment: “A case of missing pathology in a patient with LRRK2 Parkinson's disease”
    2019
    Summary Details
    RESTRICTED
    Title: Expert comment: “A case of missing pathology in a patient with LRRK2 Parkinson's disease”
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.11.005
    Citation Count: 3
  • Summary Details
    OPEN
    Title: Activation of endogenous PRKN by structural derepression is linked to increased turnover of the E3 ubiquitin ligase
    Journal Name: Autophagy
    Publisher: Informa UK Limited
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1080/15548627.2025.2531025
    Citation Count: 4
  • Summary Details
    OPEN
    Title: Chalcones and Five-Membered Heterocyclic Isosteres Bind to Alpha Synuclein Fibrils in Vitro
    Journal Name: ACS Omega
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: publisher-specific-oa
    DOI - Digital Object Identifier: 10.1021/acsomega.7b01897
    Citation Count: 41
  • Summary Details
    OPEN
    Title: Disruption of the LRRK2 substrate RAB12 facilitates neurotransmission and causes hyperactivity in mice
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1038/s41531-026-01353-4
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Network Connectivity Alterations across the MAPT Mutation Clinical Spectrum
    Journal Name: Annals of Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1002/ana.26738
    Citation Count: 7
  • Summary Details
    OPEN
    Title: A sensitive assay reveals structural requirements for α-synuclein fibril growth
    Journal Name: Journal of Biological Chemistry
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1074/jbc.m116.767053
    Citation Count: 30
  • Summary Details
    OPEN
    Title: USP 14 inhibition corrects an in vivo model of impaired mitophagy
    Journal Name: EMBO Molecular Medicine
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.15252/emmm.201809014
    Citation Count: 117
  • Summary Details
    OPEN
    Title: Lack of independent mood-enhancing effect for dopaminergic medications in early Parkinson's disease
    Journal Name: Journal of the Neurological Sciences
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.jns.2019.05.009
    Citation Count: 6
  • Summary Details
    OPEN
    Title: Persistent activation of the D1R/Shp-2/Erk1/2 pathway in l-DOPA-induced dyskinesia in the 6-hydroxy-dopamine rat model of Parkinson's disease
    Journal Name: Neurobiology of Disease
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.nbd.2013.01.005
    Citation Count: 41
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.